Defense specialist Exosens hits the stock market
Exosens, specialist in high-tech sensors for defense and nuclear power, is going public in a few days with a valuation of more than a billion euros. The price of 20 euros per share demonstrates the confidence of investors in this French nugget. In just three years, Exosens has tripled its value and is now attracting international investors.
Formerly known as Photonis, Exosens has transformed itself to become a key player in the defense market. Initially taken over by the HLD holding company for 370 million euros after the Ministry of the Armed Forces vetoed the American Teledyne, the company has now reached an impressive valuation. HLD will value 2.7 times its initial investment.
Strategic partnerships and growth prospects
Exosens relies on strategic investors to solidify its economic position. HLD, retaining more than 58% of the shares, is supported by Bpifrance (4.6%) and CDC Tech Premium (2.95%), thus strengthening the company’s French roots. Two Anglo-Saxon investors also hold significant shares, reflecting international economic confidence.
Since its independence, Exosens has made five strategic acquisitions, including companies specializing in infrared cameras, methane leak detection and the manufacturing of particle detectors. These acquisitions aim to diversify the company’s activities. In fact, the latter tend to strengthen the company’s position in other key economic markets such as health and renewable energies. Proof of current confidence, Exosens management plans to double turnover by 2027.
